Quick Summary
CTX GLS 200mg Injection
Last updated on 31 Mar 2026 | 09:31 AM (IST)
₹28
MRP: ₹36
(You Save ₹8)
1 VIAL(s)
22% OFF
₹28
MRP: ₹36.00
Inclusive of all taxes
22% Off
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Cyphos 200mg Injection
GETWELL ONCOLOG...
₹ 31.00/injection
11% costlier
Uniphos 200mg Injection
UNITED BIOTECH ...
₹ 34.00/injection
22% costlier
Phoxelon 200mg Injection
CELON LABORATOR...
₹ 38.00/injection
36% costlier
Nuphos 200mg Injection
ZEE LABORATORIE...
₹ 42.00/injection
50% costlier
Introduction to CTX GLS 200mg Injection
CTX GLS 200mg Injection is a chemotherapy drug containing the active constituent cyclophosphamide. It is used to treat various malignancies (abnormal production of cells is called cancer, and if they spread to other organs, they are called malignancies). CTX GLS 200mg Injection can be used to treat malignant lymphomas (cancers that start from the lymphatic system of the body- vessels, fluid, and lymphoid tissue) such as Hodgkin’s disease, lymphocytic lymphoma, and mixed-cell type lymphoma.
It is used to treat leukemias, neuroblastoma, ovarian cancer, retinoblastoma, and breast carcinoma. It can also treat Minimal Change Nephrotic syndrome in pediatric patients (kidney disease in which large quantities of protein are lost in urine). CTX GLS 200mg Injection is contraindicated in pregnancy, patients with acute infections, urinary tract infections, urinary outflow obstruction, and bone marrow disorders.
Treatment with this medicine may lead to immune suppression, bone marrow failure, cardiotoxicity, renal toxicity, pulmonary toxicity, and secondary malignancies. Inform your doctor if you have pre-existing kidney disease, immune conditions, cardiac disorders, or liver diseases.
Uses of CTX GLS 200mg Injection
- Malignant lymphomas
- Leukemias
- Retinoblastoma
- Carcinoma of breast
- Ovarian cancer
- Mycosis fungoides
- Minimal Change Nephrotic Syndrome in Pediatric Patients
Therapeutic Effects of CTX GLS 200mg Injection
CTX GLS 200mg Injection Injection slows or stops the growth of cancer cells by damaging the hereditary material (DNA and RNA) of the cancer cells. In nephrotic syndrome, it works by suppressing the body’s immune system.
Interaction of CTX GLS 200mg Injection with other drugs
Inform your doctor about any prescribed medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products that you are taking or have taken before the treatment. Certain medications may interact with CTX GLS 200mg Injection and cause potential side effects.
More Information about CTX GLS 200mg Injection
Keep out of sight and reach of children. Store vials below or at 25°C.
How to consume CTX GLS 200mg Injection
CTX GLS 200mg Injection will be administered intravenously by healthcare professionals experienced in cancer chemotherapy. Do not self-administer.
Safety Advice for CTX GLS 200mg Injection
Breast Feeding
Avoid CTX GLS 200mg Injection if you are breastfeeding. Consult your doctor for potential risks and benefits.
Alcohol
It is unsafe to consume alcohol with CTX GLS 200mg Injection. Please consult your doctor for more advice.
Liver
CTX GLS 200mg Injection should be used with caution in patients with liver disease. Please consult your doctor.
Lungs
It is unknown whether CTX GLS 200mg Injection can be given in lung failure patients. Inform your doctor if you have any lung diseases.
Driving
It is not recommended while driving because it causes dizziness, and patients may lack concentration and alertness.
Pregnancy
CTX GLS 200mg Injection can cause fetal harm when administered to a pregnant woman. Inform your physician if you are pregnant or planning to get pregnant before taking this medication. Your physician will instruct you to take it when it is necessary.
Side Effects of CTX GLS 200mg Injection
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious
- Infections
- Immune suppression
- Blood disorders
- Allergic reactions
- Abnormal liver function
- Inflammation of the bladder
- Kidney diseases
- blood in urine
- sterility
- impaired wound healing
Common
- Nausea, vomiting
- Low white blood cell count
- Diarrhea
- Hair loss
- Fever
- Weakness
- Inflammation
- Dizziness
- Blurred vision
- amenorrhea
Word of Advice
Inform the doctor if the patient has any kidney, liver, or heart problems and medication taken for different medical conditions. It causes immune suppression, and hence inform the doctor if there are any immune problems. Avoid this medication if the patient is pregnant or breastfeeding mother. The patient undergoing treatment with CTX GLS 200mg Injection may have dizziness and blurred vision. Consult your doctor before driving and handling heavy machines.
FAQs about CTX GLS 200mg Injection
Q1.
Can CTX GLS 200mg Injection cause infertility?
Yes, CTX GLS 200mg Injection can cause infertility in both men and women hence consult the doctor before taking this medication.
Q2.
Is CTX GLS 200mg Injection chemotherapy medication?
Yes, CTX GLS 200mg Injection is a chemotherapy medicine, and it works by killing cancer cells. It prevents the spreading of cancer cells to different parts.
Q3.
Can CTX GLS 200mg Injection cause weight loss?
Yes, CTX GLS 200mg Injection causes weight loss due to reduced appetite, and consult the doctor if there is excessive weight loss.
Q4.
Can CTX GLS 200mg Injection be used during pregnancy?
No, it is highly unsafe to use this medication during pregnancy as it can cause harmful effects on the developing baby.
Q5.
Can CTX GLS 200mg Injection cause hair loss?
Yes, CTX GLS 200mg Injection can cause hair loss, and consult the doctor if there is excessive hair loss.
Q6.
Can I take CTX GLS 200mg Injection while driving?
No, it is not recommended while driving because it makes patients dizzy, and patients may lack concentration and alertness.
Fact Box of CTX GLS 200mg Injection
| Molecule Name: Cyclophosphamide | Therapeutic Class: 1. Anti-cancer 2. Antirheumatic 3. Immunomodulators |
| Pharmacological Class: Alkylating agent | Indications: 1. Malignant lymphomas 2. Treat certain types of cancers such as eye, blood, breast, and ovarian cancer. 3. Minimal Change Nephrotic Syndrome in Pediatric Patients |
References
- KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 860.
- Baxter, Electronic medicines compendium (emc), [ Revised on June 2016] [ Accessed on 8th April 2021], https://www.medicines.org.uk/emc/product/1815/smp
- Baxter, US Food and Drug Administration, [ Revised on May 2013] [ Accessed on 7th April 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/012141s090,012142s112lbl.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Guruvigneshwari M.
M. Pharm
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:31 AM (IST)
Want to know more?
Read Our Editorial Policy
